AVENUE THERAPEUTICS, INC. (ATXI)
Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care environments within hospitals. Their leading product candidate is intravenous Tramadol, a synthetic opioid with a dual mechanism of action, currently undergoing Phase III clinical trials for the management of severe pain experienced by patients after surgery. Established in 2015, the company's operations are based in New York, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Avenue Therapeutics, Inc.
OTC:ATXIHealthcare · Biotechnology
+7.08%$0.4123
Mkt Cap$1.36M
Float2.96M
O/S3.29M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.4M
Net Income-$2.91M
Total Assets$2.93M
Free Cash Flow-$1.83M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$1.83M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:75Reverse splitApr 26, 202475 shares → 1
- 1:15Reverse splitSep 23, 202215 shares → 1
Balance Sheet Details
Assets$2.93M
Liabilities$1.1M
Accounts Receivable$0
Accounts Payable$94K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $1.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $1.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | 100.0% | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $1.04M | $6.64M | $10.36M | $2.7M | $1.25M | $2.87M | $23.19M | $17.7M | $7.8M | $1.38M | $4M |
| Selling, General, and Administrative | $3.65M | $4.64M | $4.18M | $5.34M | $2.48M | $2.35M | $3.07M | $4.12M | $3.62M | $997K | $842K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $175K | -$99K | $0 | $0 |
| Total Operating Expenses | $4.69M | $11.28M | $14.54M | $8.04M | $3.74M | $5.21M | $26.27M | $21.82M | $6.7M | $2.38M | $4.84M |
| Operating Income (EBIT) | -$3.29M | -$11.28M | -$14.54M | -$8.04M | -$3.74M | -$5.21M | -$26.27M | -$21.82M | -$11.42M | -$2.38M | -$4.84M |
| Operating Margin | -234.0% | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $1.16M | $0 | $0 | $0 | $0 | $375K | $612K | $418K |
| Interest Income | $121K | $176K | $126K | $20K | $7K | $62K | $357K | $93K | $88K | $0 | $0 |
| Other Income (Expense) | $339K | -$413K | $4.05M | $4.44M | $7K | $62K | $357K | $268K | -$837K | -$800K | -$383K |
| Income Before Tax (EBT) | -$2.95M | -$11.7M | -$10.49M | -$3.6M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M | -$5.23M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$268K | $0 | $0 | $0 |
| Net Income | -$2.91M | -$11.65M | -$10.38M | -$3.55M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M | -$5.23M |
| Net Income Margin | -207.2% | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -0.93 | -0.90 | -73.60 | -121.91 | -3.29 | -4.65 | -24.38 | -31.17 | -27.71 | -5.39 | -9.40 |
| Diluted EPS | -0.93 | -0.90 | -73.48 | -121.91 | -3.29 | -4.65 | -24.38 | -31.17 | -27.71 | -5.39 | -9.40 |
| Weighted Average OS | 3.13M | 12.95M | 141,000 | 29,135 | 1.13M | 1.10M | 1.05M | 682,611 | 442,329 | 589,431 | 556,098 |
| EBITDA | -$3.29M | -$11.7M | $4.05M | -$2.44M | $7K | -$5.15M | -$25.91M | $268K | -$11.71M | -$188K | $440K |
| EBITDA Margin | -234.0% | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $11.78M | $197K | $14K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10M | $0 | $0 |
| Cash and Short-Term Investments | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $21.78M | $197K | $14K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $90K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $78K | $0 | $0 | $0 | $0 | $0 | $1.7M | $0 | $0 | $0 |
| Total Current Assets | $2.85M | $2.67M | $1.85M | $6.84M | $3.96M | $3.25M | $8.91M | $4.53M | $22.17M | $197K | $14K |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $67K | $0 | $0 | $113K | $170K | $1.85M | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $0 | $67K | $0 | $0 | $113K | $170K | $1.85M | $0 | $0 | $0 |
| Other Assets | $76K | $0 | -$67K | $0 | $0 | -$113K | -$170K | -$1.85M | $0 | $0 | $0 |
| Total Assets | $2.93M | $2.67M | $1.85M | $6.84M | $3.96M | $3.25M | $8.91M | $4.53M | $22.17M | $197K | $14K |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $94K | $155K | $401K | $150K | $304K | $172K | $354K | $3.09M | $1.54M | $334K | $491K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.85M | $1.17M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.75M | $0 |
| Other Current Liabilities | $182K | $34K | $784K | $2.61M | $24K | $0 | $1M | $0 | $0 | $1.66M | $114K |
| Total Current Liabilities | $1.1M | $816K | $1.2M | $3.58M | $509K | $886K | $2.12M | $5.16M | $2.79M | $6.42M | $2K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.03M | $2.7M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.03M | $3K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.1M | $816K | $1.2M | $3.58M | $509K | $886K | $2.12M | $5.16M | $2.79M | $8.45M | $5.15M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $3K | $0 | $0 | $2K | $2K | $1K | $1K | $1K | $1K |
| Retained Earnings | -$105.49M | -$102.58M | -$90.93M | -$80.55M | -$77M | -$73.27M | -$68.12M | -$42.21M | -$20.66M | -$8.4M | -$5.23M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.1M | $49K | $40K |
| Other Stockholders' Equity | $107.32M | $105.38M | $92.51M | $84.46M | $80.45M | $75.63M | $74.92M | $41.58M | $40.04M | $154K | $90K |
| Total Equity | $1.83M | $2.8M | $1.58M | $3.9M | $3.45M | $2.36M | $6.8M | -$631K | $19.38M | -$8.25M | -$5.13M |
| Minority Interest | $0 | -$941K | -$928K | -$639K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.93M | $3.61M | $2.78M | $7.48M | $3.96M | $3.25M | $8.91M | $4.53M | $22.17M | $197K | $14K |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.87M | $3.87M |
| Net Debt | -$2.85M | -$2.59M | -$1.78M | -$6.71M | -$3.76M | -$3.13M | -$8.74M | -$2.67M | -$11.78M | $5.68M | $4K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$2.91M | -$11.7M | -$10.38M | -$3.6M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M | -$5.23M |
| Depreciation & Amortization | $0 | $0 | $14.54M | $0 | $3.74M | $0 | $0 | $21.82M | $174K | $2.38M | $5.28M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $277K | $0 | $0 |
| Stock-Based Compensation | $665K | $1.24M | $906K | $649K | $442K | $710K | $1.84M | $1.54M | $604K | $28K | $56 |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $90K | -$90K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $298K | $0 | -$360K | $0 | $0 | -$229K | -$3.23M | $1.13M | $2.23M | $15K | $0 |
| Other Working Capital | $2K | $179K | $70K | $318K | -$371K | $57K | $982K | $670K | -$154K | $1.07M | $1.17M |
| Total Working Capital Change | $300K | $179K | -$290K | $408K | -$461K | -$172K | -$2.25M | $1.79M | $2.08M | $1.08M | $1.17M |
| Other Non-Cash Items | $111K | $1.25M | -$14.23M | -$5.05M | -$3.74M | $0 | $61K | -$21.82M | $2.32M | -$1.94M | -$2.12M |
| Net Cash from Operating | -$1.83M | -$9.03M | -$9.45M | -$7.6M | -$3.75M | -$4.61M | -$26.26M | -$18.22M | -$6.8M | -$1.63M | -$895K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | -$1M | $0 | $0 | $0 | $0 | -$3M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | -$5M | $10M | -$10M | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $5M | $10M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | -$3M | $0 | $0 | $0 | $0 | -$10M | -$10K | $0 | -$3K |
| Net Cash from Investing | $0 | $0 | -$3M | $0 | $0 | -$1M | $0 | $10M | -$10M | $0 | -$3M |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | $3M | -$200K | -$3.91M |
| Common Stock Issuance | $2.09M | $1.62M | $7.53M | $11.5M | $5.04M | $0 | $35M | -$895K | $37.95M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | -$1.1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $8.21M | $1K | $148K | -$663K | $0 | -$2.67M | -$895K | -$6.56M | -$58K | $0 |
| Net Cash from Financing | $2.09M | $9.84M | $7.53M | $10.54M | $4.38M | $0 | $32.33M | -$895K | $28.39M | $1.81M | $3.91M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $261K | $811K | -$4.92M | $2.94M | $631K | -$5.61M | $6.07M | -$9.11M | $11.59M | $183K | $14K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$1.83M | -$9.03M | -$9.45M | -$7.6M | -$3.75M | -$4.61M | -$26.26M | -$18.22M | -$6.8M | -$1.63M | -$895K |
| Capital Expenditure | $0 | $0 | -$3M | $0 | $0 | -$1M | $0 | $0 | $0 | $0 | -$3M |
| Free Cash Flow | -$1.83M | -$9.03M | -$12.45M | -$7.6M | -$3.75M | -$5.61M | -$26.26M | -$18.22M | -$6.8M | -$1.63M | -$3.9M |
| Cash at Beginning | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $11.78M | $197K | $14K | $0 |
| Cash at End | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $11.78M | $197K | $14K |